FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

35025711000001101: Testosterone 16.2mg/g gel (20.25mg per actuation) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 24-Jan 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
106108301000001118 Testosterone 16.2mg/g gel (20.25mg per actuation) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
106108401000001114 Testosterone 16.2mg/g gel (20.25mg per actuation) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Testosterone 16.2mg/g gel (20.25mg per actuation) Is a Testosterone true Inferred relationship Existential restriction modifier
Testosterone 16.2mg/g gel (20.25mg per actuation) Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Testosterone 16.2mg/g gel (20.25mg per actuation) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 4 (CD Anab) true Inferred relationship Existential restriction modifier
Testosterone 16.2mg/g gel (20.25mg per actuation) Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route gel.transdermal ontology form and route true Inferred relationship Existential restriction modifier
Testosterone 16.2mg/g gel (20.25mg per actuation) Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Transdermal route true Inferred relationship Existential restriction modifier
Testosterone 16.2mg/g gel (20.25mg per actuation) Is a Product containing testosterone false Inferred relationship Existential restriction modifier
Testosterone 16.2mg/g gel (20.25mg per actuation) Has active ingredient Testosterone false Inferred relationship Existential restriction modifier
Testosterone 16.2mg/g gel (20.25mg per actuation) Has dispensed dose form Gel true Inferred relationship Existential restriction modifier
Testosterone 16.2mg/g gel (20.25mg per actuation) Has specific active ingredient Testosterone true Inferred relationship Existential restriction modifier
Testosterone 16.2mg/g gel (20.25mg per actuation) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Testosterone 16.2mg/g gel (20.25mg per actuation) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Testosterone 16.2mg/g gel (20.25mg per actuation) Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Testogel 16.2mg/g gel (Besins Healthcare (UK) Ltd) Is a True Testosterone 16.2mg/g gel (20.25mg per actuation) Inferred relationship Existential restriction modifier
Testosterone 16.2mg/g gel (20.25mg per actuation) 88 gram Has VMP True Testosterone 16.2mg/g gel (20.25mg per actuation) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start